Single-cell transcriptomics reveals colonic immune perturbations during amyloid-β driven Alzheimer's disease in mice
Makhijani, P.; Emani, R.; Aguirre, C. G.; Mu, W.-C.; Rane, A.; Ng, J. H. Y.; Valentino, T. R.; Manwaring-Mueller, M.; Tan, C. R.; Du, H.; Wu, F.; Khan, S.; Wilson, K. A.; Winer, S.; Wang, C.; Mortha, A.; Furman, D.; Ellerby, L. M.; Rojas, O. L.; Andersen, J. K.; Winer, D. A.
Show abstract
The "gut-brain axis" is emerging as an important target in Alzheimers disease (AD). However, immunological mechanisms underlying this axis remain poorly understood. Using single-cell RNA sequencing of the colon immune compartment in the 5XFAD amyloid-{beta} (A{beta}) mouse model, we uncovered AD-associated changes in ribosomal activity, oxidative stress, and BCR/plasma cell activity. Strikingly, levels of colon CXCR4+ antibody secreting cells (ASCs) were significantly reduced. This corresponded with accumulating CXCR4+ B cells and gut-specific IgA+ cells in the brain and dura mater, respectively. Consistently, a chemokine ligand for CXCR4, CXCL12, was expressed at higher levels in 5XFAD glial cells and in in silico analyzed human brain studies, supporting altered neuroimmune trafficking. An inulin prebiotic fiber diet attenuated AD markers including A{beta} plaques and overall frailty. These changes corresponded to an expansion of gut IgA+ cells and rescued peripheral Tregs levels. Our study points to a key glia-gut axis and potential targets against AD. Study HighlightsO_LIAD is associated with altered immune parameters in the gut of 5XFAD mice. C_LIO_LI5XFAD colon has reduced ASCs, including CXCR4+ cells with a migratory gene signature. C_LIO_LI5XFAD brain gliosis includes increased CXCL12 expression. C_LIO_LICXCR4+ B cells and gut-specific IgA+ ASCs accumulate in the 5XFAD brain and/or dura mater. C_LIO_LIInulin diet attenuates AD disease parameters while boosting IgA+ cell and Treg levels. C_LI
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression 95%
- Deletion of the microglial transmembrane immune signaling adaptor TYROBP ameliorates Huntington's disease mouse phenotype 94%
- AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer's disease 94%
Similar papers in this journal
- Epithelial antigen presentation controls commensal-specific intraepithelial T-cells in the gut 93%
- GSAP regulates mitochondrial function through the Mitochondria-associated ER membrane in the pathogenesis of Alzheimer's disease 93%
- ICOS signaling limits regulatory T cell accumulation and function in visceral adipose tissue 92%
Similar papers in this journal
- p16High immune cell - controlled disease tolerance as a broad defense and healthspan extending strategy 92%
- Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration 92%
- Genetic, environmental and intrinsic determinants of the human antibody epitope repertoire 91%
Similar papers in this journal
- Sustained TREM2 stabilization accelerates microglia heterogeneity and Abeta pathology in a mouse model of Alzheimer s disease 95%
- Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer's disease 95%
- Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signaling 94%